Bausch plus Lomb Corporation (BLCO) ニュース

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors

Richard De Schutter to Retire from Board Following 2024 Annual Meeting Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health...

Form 8-K - Current report

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying...

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance

Fourth-Quarter 2023 Financial Results Revenue of $1.173 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $54 Million Adjusted...

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will...

Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery

First Excimer Platform Approved in Nearly Two Decades Offers Accuracy, Efficiency and Usability Advantages Bausch + Lomb Corporation (NYSE/TSX:...

Form 4 - Statement of changes in beneficial ownership of securities

Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today...

Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today...

Form 8-K/A - Current report: [Amend]